CMS certification 210008
Mercy Medical Center INC
301 Saint Paul Place, Baltimore, MD 21202
Mercy Medical Center has a CMS overall rating of 3 out of 5 stars. 80% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 23 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 2 and worse on 2. Emergency patients spend a median of 3 h 57 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 697 completed surveys, 26% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | MD | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 375 visits sampled | 3 h 57 min | 4 h 6 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 14 visits sampled | 4 h 8 min | 6 h 55 min | 4 h 17 min |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 12 patients | 83% | 69% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 128 patients | 91% | 65% | 65% |
How Mercy Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Mercy Medical Center INCThis hospital | 3/5 | 80% | 3 h 57 min | 2 better 2 worse |
| University of Maryland Medical CenterSame city | 3/5 | 70% | 5 h 9 min | 2 better 2 worse |
| University of MD Medical Center Midtown CampusSame city | 3/5 | 66% | 4 h 3 min | 1 better 1 worse |
| VA Maryland Healthcare System - BaltimoreSame city | 2/5 | 56% | — | 1 better 3 worse |
| Greater Baltimore Medical CenterSame city | 5/5 | 77% | 3 h 48 min | 6 better 1 worse |
| Sinai Hospital of BaltimoreSame city | 3/5 | 61% | 4 h 17 min | 4 better 6 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Baltimore.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 1,642 cases | Too few cases | 3.8% | 3.9% |
| Heart failure 131 cases | Too few cases | 10.1% | 11.1% |
| Pneumonia 88 cases | Too few cases | 17.9% | 15.2% |
| Stroke 52 cases | Too few cases | 13.1% | 11.9% |
| COPD 57 cases | Too few cases | 8.4% | 8.6% |
2 more measures had too few cases here to report.
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1 likely 0.69 – 1.32 | 1 |
| After hip or knee replacement 66 cases | Too few cases | 5.3% | 4.1% |
| Deaths after a serious but treatable surgical complication 61 cases | No different | 198.47 per 1,000 likely 143.86 per 1,000 – 253.07 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 3,226 cases | No different | 1.1 per 1,000 likely 0.27 per 1,000 – 1.93 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 4,046 cases | No different | 0.28 per 1,000 likely 0.07 per 1,000 – 0.5 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 4,248 cases | No different | 0.26 per 1,000 likely 0.06 per 1,000 – 0.46 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 2,089 cases | No different | 3.49 per 1,000 likely 2.17 per 1,000 – 4.82 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,586 cases | No different | 1.23 per 1,000 likely 0 per 1,000 – 2.72 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,584 cases | No different | 5.74 per 1,000 likely 0.44 per 1,000 – 11.04 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 2,149 cases | No different | 3.97 per 1,000 likely 2.13 per 1,000 – 5.82 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,529 cases | No different | 3.83 per 1,000 likely 0.84 per 1,000 – 6.82 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 749 cases | No different | 1.84 per 1,000 likely 0.41 per 1,000 – 3.27 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,572 cases | No different | 0.67 per 1,000 likely 0 per 1,000 – 1.54 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.57 likely 0.21 – 1.25 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.77 likely 0.31 – 1.6 | 1 |
| Surgical site infections after colon surgery | No different | 0.46 likely 0.12 – 1.25 | 1 |
| Surgical site infections after abdominal hysterectomy | Better | 0.13 likely 0.01 – 0.62 | 1 |
| MRSA bloodstream infections | No different | 0 | 1 |
| C. diff intestinal infections | No different | 0.79 likely 0.52 – 1.15 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after heart failure 193 cases | Too few cases | 21.8% | 21.3% |
| Readmitted after pneumonia 109 cases | Too few cases | 17.5% | 17.3% |
| Readmitted after COPD 116 cases | Too few cases | 20.7% | 20% |
| Readmitted after hip or knee replacement 61 cases | Too few cases | 6.3% | 5.8% |
| Days back in hospital after heart failure 157 cases | Too few cases | 77.7 days per 100 | — |
| Days back in hospital after pneumonia 80 cases | Too few cases | 58.1 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 2,554 cases | No different | 12.8 per 1,000 likely 10.1 per 1,000 – 16.1 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 272 cases | No different | 8.9 per 100 likely 6.6 per 100 – 11.9 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 272 cases | No different | 4.6 per 100 likely 3.3 per 100 – 6.7 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 1,784 cases | Better | 0.7 likely 0.6 – 0.9 | — |
4 more measures had too few cases here to report.
Clinicians registered at this address
245 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Physician Assistant | 27 |
| Internal Medicine | 26 |
| Surgical | 13 |
| Orthopaedic Surgery | 11 |
| Anesthesiology | 10 |
| Physical Therapist | 10 |
| Advanced Practice Midwife | 7 |
| Clinical | 6 |
| Emergency Medicine | 6 |
| Family | 6 |
| Nurse Anesthetist, Certified Registered | 6 |
| Obstetrics & Gynecology | 6 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $1.3M
- 2020 $708,668
- 2021 $1.1M
- 2022 $1M
- 2023 $0
- 2024 $1.6M
- 2025 $1.6M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $849,446 | 20 |
| Space rental and facility fees | $118,000 | 29 |
| Medical devices and supplies on long-term loan | $20,557 | 4 |
| Speaking, teaching and other services | $6,500 | 3 |
| Charitable contributions | $3,500 | 1 |
| Debt forgiveness | $848 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Boston Scientific Corporation | $417,920 | 8 |
| Olympus Corporation of the Americas | $371,026 | 7 |
| Takeda Pharmaceuticals U.S.A., Inc. | $282,819 | 5 |
| Pfizer INC. | $228,220 | 18 |
| AstraZeneca Pharmaceuticals LP | $111,319 | 6 |
| Intuitive Surgical, INC. | $50,178 | 2 |
| Baxter Healthcare | $45,000 | 1 |
| Gilead Sciences, Inc. | $14,083 | 4 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| Real world study of efficacy and adherence to subcutaneous vs. intravenous vedolizumab in patients with inflammatory bowel disease using a novel remo… Takeda Pharmaceuticals U.S.A., Inc. | $276,319 |
| A RANDOMIZED DOUBLEBLIND PHASE 3 STUDY OF TUCATINIB OR PLACEBO IN COMBINATION WITH TRASTUZUMAB AND PERTUZUMAB AS MAINTENANCE THERAPY FOR METASTATIC H… PFIZER INC. | $153,752 |
| A Phase 3 Open-label, Randomised Study of Datopotamab Deruxtecan?(DatoDXd) With or Without Durvalumab Versus Investigators Choice of Therapy in Patie… AstraZeneca Pharmaceuticals LP | $63,366 |
| AN INTERVENTIONAL OPENLABEL RANDOMIZED MULTICENTER PHASE 3 STUDY OF PF07220060 PLUS LETROZOLE COMPARED TO CDK46 INHIBITOR PLUS LETROZOLE IN PARTICIPA… PFIZER INC. | $57,323 |
| Artemide Lung02 a phase III global study of rilvegostomig or pembrolizumab for patients with metastatic squamous non small cell lung cancer AstraZeneca Pharmaceuticals LP | $14,791 |
| A Phase III Randomized Double blind Multicenter Global Study of Rilvegostomig or Pembrolizumab in Combination with Platinum based Chemotherapy for th… AstraZeneca Pharmaceuticals LP | $14,791 |
| A Phase III, Randomised, Open-label, Global Study of Adjuvant Datopotamab Deruxtecan (Dato-DXd) in Combination With Rilvegostomig or Rilvegostomig Mo… AstraZeneca Pharmaceuticals LP | $13,291 |
| AN INTERVENTIONAL OPENLABEL RANDOMIZED MULTICENTER PHASE 3 STUDY OF PF07248144 PLUS FULVESTRANT COMPARED TO INVESTIGATORS CHOICE OF THERAPY IN ADULT … PFIZER INC. | $10,645 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Mercy Medical Center
Is Mercy Medical Center a good hospital?
Mercy Medical Center has a CMS overall rating of 3 out of 5 stars. Of the 23 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 2 and worse on 2. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Mercy Medical Center?
80% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 697 completed HCAHPS surveys.
How long is the wait in the Mercy Medical Center emergency room?
Emergency patients spend a median of 3 h 57 min in its emergency department before leaving (US median 2 h 42 min). These are medians over a year of visits, not a live wait time.
Does Mercy Medical Center receive money from drug and device companies?
Drug and device makers reported $1.6M in payments to Mercy Medical Center for 2025, under the federal Open Payments program. A payment on its own does not show a conflict of interest.